Article metrics

Download PDFPDF

FRI0512 Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (156-week) improvements in basdai in psoriatic arthritis patients: pooled results from 3 phase iii, randomized, controlled trials
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to May 2024

AbstractFullPdf
Jun 20172203
Jul 20173604
Aug 20171601
Sep 20173002
Oct 20172804
Nov 20173206
Dec 20171000
Jan 20182205
Feb 20182301
Mar 2018800
Apr 2018601
May 20181402
Jun 20182201
Jul 20182001
Aug 20181601
Sep 2018602
Oct 2018801
Nov 2018601
Dec 2018402
Jan 20191602
Feb 20191805
Mar 2019803
Apr 2019805
May 20191807
Jun 2019400
Jul 2019202
Aug 2019403
Oct 2019402
Nov 2019002
Dec 2019800
Jan 2020601
Feb 20201008
Mar 2020805
Apr 2020804
May 2020403
Jun 2020600
Jul 2020604
Aug 2020202
Sep 20201604
Oct 20201202
Nov 2020402
Dec 2020600
Jan 20211004
Feb 2021806
Mar 2021803
Apr 20211201
May 2021205
Jun 2021006
Jul 2021002
Aug 2021001
Sep 2021002
Oct 20216016
Nov 20215020
Dec 20211807
Jan 2022401
Feb 2022200
Mar 202212020
Apr 2022001
May 20221005
Jun 20221004
Jul 2022800
Aug 20221804
Sep 2022205
Oct 20221204
Nov 2022803
Dec 2022601
Jan 2023202
Feb 2023201
Mar 2023800
Apr 2023604
May 2023603
Jul 2023204
Aug 2023001
Sep 2023001
Oct 2023001
Nov 2023001
Dec 20231200
Jan 20241400
Feb 2024203
Mar 20242014
Apr 2024604
May 2024400
Total7340264